- Home
- HMR vs HOWL Comparison
HMR vs HOWL Comparison
Compare HMR & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HMR | HOWL |
|---|---|---|
| Founded | 1984 | 2017 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.1M | 64.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | HMR | HOWL |
|---|---|---|
| Price | $1.09 | $0.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $6.00 | ★ $7.00 |
| AVG Volume (30 Days) | 43.1K | ★ 540.4K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $36,086,264.00 | N/A |
| Revenue This Year | $52.26 | N/A |
| Revenue Next Year | $45.18 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.41 | N/A |
| 52 Week Low | $1.07 | $0.60 |
| 52 Week High | $10.04 | $2.38 |
Technical Indicators
Market Signals| Indicator | HMR | HOWL |
|---|---|---|
| Relative Strength Index (RSI) | 34.67 | 41.36 |
| Support Level | $1.11 | $0.82 |
| Resistance Level | $1.14 | $1.03 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 14.29 | 65.96 |
Price Performance
Historical ComparisonAbout HMR Heidmar Maritime Holdings Corp. Common Stock
Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. The company is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management. The company generates maximum revenue from Singapore.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.